Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in IndiaThomas Bollyky
Apr. 14, 2013
German Officials Respond to Migrant's Axe Attack by Calling for 'Mandatory Islam Classes'
Steve King Doubles Down: Idea Every Culture is Equal "Not Objectively True"
Finland: Man Thrown in Prison For Using "Excessive Self-Defense" Against Home Invaders
Black Lives Matter Protesters Block Bridge During Child's Medical Emergency
Report: Murdoch Son 'Horrified by Potential Trump Presidency' Forced Out Roger Ailes
Why does Gleevec, a leukemia drug that costs $70,000 per year in the United States, cost just $2,500 in India?
It's seemingly simple. Gleevec is under patent in the U.S., but not in India. Accordingly, Novartis, its Swiss-based manufacturer, may prevent competitors from making and selling lower-cost versions of the drug in the U.S., but not in India.